| Product Code: ETC13150681 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Next Generation Sequencing Market was valued at USD 18 Billion in 2024 and is expected to reach USD 32 Billion by 2031, growing at a compound annual growth rate of 6.30% during the forecast period (2025-2031).
The global next-generation sequencing (NGS) market is experiencing significant growth driven by advancements in technology, declining sequencing costs, and increasing applications in areas such as oncology, personalized medicine, and agriculture. Key players in the market include Illumina, Thermo Fisher Scientific, and Oxford Nanopore Technologies. The adoption of NGS in clinical diagnostics and research settings is expanding, fueled by the demand for precision medicine and genomic-based treatments. The Asia-Pacific region is projected to witness the highest growth due to the rising healthcare infrastructure and government initiatives supporting genomics research. However, challenges such as data management, interpretation, and ethical considerations remain. Overall, the NGS market is poised for continued expansion, with innovations in sequencing technologies and bioinformatics driving further growth and adoption across various industries.
The Global Next Generation Sequencing (NGS) market is experiencing significant growth and innovation driven by advancements in technology, increased applications in precision medicine, and rising demand for personalized healthcare solutions. Key trends include the adoption of cloud-based NGS platforms, integration of artificial intelligence and machine learning for data analysis, and the development of rapid and cost-effective sequencing technologies. Opportunities in the market lie in expanding applications in cancer research, infectious disease diagnostics, and agricultural genomics, as well as the increasing use of NGS in clinical settings for disease diagnosis and treatment selection. Additionally, collaborations between NGS companies and healthcare providers are on the rise, facilitating the integration of genomic data into routine clinical practice. Overall, the Global NGS market is poised for continued growth and innovation in the coming years.
The Global Next Generation Sequencing Market faces several challenges, including high costs associated with NGS technology, data analysis complexity, and standardization issues. The initial investment required for NGS instruments and reagents can be prohibitive for many research institutions and clinical labs, limiting widespread adoption. Furthermore, the vast amount of data generated by NGS requires sophisticated analysis tools and bioinformatics expertise, which can be a barrier for smaller facilities. Standardization of protocols and data formats across different NGS platforms is also a challenge, impacting data comparability and hindering collaboration between researchers. Overcoming these challenges will be crucial for the continued growth and advancement of the Global Next Generation Sequencing Market.
The Global Next Generation Sequencing (NGS) market is being primarily driven by technological advancements leading to cost reduction and increased sequencing speed, growing applications of NGS in clinical diagnostics, oncology, and personalized medicine, as well as the rising prevalence of genetic disorders and cancer. The increasing focus on precision medicine and the need for better understanding of complex biological systems are also fueling the demand for NGS technologies. Furthermore, the availability of government funding and initiatives for genomics research, along with collaborations between academic research institutions and industry players, are contributing to the market growth. Additionally, the expanding use of NGS in agriculture and animal research sectors is expected to further boost the market in the coming years.
Government policies related to the Global Next Generation Sequencing Market vary by country. In the United States, the FDA regulates NGS-based tests as in vitro diagnostic devices, requiring them to meet certain performance standards before being marketed. The Centers for Medicare and Medicaid Services (CMS) also play a role by determining reimbursement rates for NGS tests. In the European Union, the In Vitro Diagnostic Regulation (IVDR) sets out requirements for the performance, safety, and quality of NGS tests to ensure patient safety and data accuracy. Additionally, many countries have data protection laws that impact the use and sharing of genetic information obtained through NGS. Overall, government policies aim to balance innovation and patient safety while promoting the growth of the NGS market.
The Global Next Generation Sequencing Market is expected to experience significant growth in the coming years due to advancements in technology, declining costs of sequencing, and increasing application in various fields such as personalized medicine, oncology, and agriculture. The market is projected to expand as more healthcare providers and research institutions adopt NGS technology for diagnostics, drug discovery, and genetic research. Additionally, the growing awareness about the benefits of precision medicine and the rising prevalence of genetic disorders are driving the demand for NGS platforms. Emerging trends like cloud-based sequencing and the integration of artificial intelligence are also expected to propel market growth. Overall, the Global Next Generation Sequencing Market is anticipated to thrive, offering lucrative opportunities for key players in the industry.
The global next-generation sequencing market is experiencing significant growth across regions. In Asia, countries like China and India are witnessing a surge in NGS adoption due to increasing investments in healthcare infrastructure and research activities. North America remains a key market player with advanced technological developments and a strong presence of key NGS companies. Europe is also a prominent market, driven by government initiatives supporting genomics research and precision medicine. The Middle East and Africa region is showing gradual growth with a focus on personalized medicine and increasing awareness about NGS technologies. Latin America is witnessing a rise in NGS applications in agriculture and livestock research, along with expanding healthcare infrastructure contributing to market growth in the region.
Global Next Generation Sequencing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Next Generation Sequencing Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Next Generation Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 Global Next Generation Sequencing Market - Industry Life Cycle |
3.4 Global Next Generation Sequencing Market - Porter's Five Forces |
3.5 Global Next Generation Sequencing Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Next Generation Sequencing Market Revenues & Volume Share, By Sequencing Type, 2021 & 2031F |
3.7 Global Next Generation Sequencing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 Global Next Generation Sequencing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.9 Global Next Generation Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 Global Next Generation Sequencing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Next Generation Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Next Generation Sequencing Market Trends |
6 Global Next Generation Sequencing Market, 2021 - 2031 |
6.1 Global Next Generation Sequencing Market, Revenues & Volume, By Sequencing Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Next Generation Sequencing Market, Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031 |
6.1.3 Global Next Generation Sequencing Market, Revenues & Volume, By Targeted Resequencing, 2021 - 2031 |
6.1.4 Global Next Generation Sequencing Market, Revenues & Volume, By Whole Exome Sequencing, 2021 - 2031 |
6.1.5 Global Next Generation Sequencing Market, Revenues & Volume, By RNA Sequencing, 2021 - 2031 |
6.1.6 Global Next Generation Sequencing Market, Revenues & Volume, By CHIP Sequencing, 2021 - 2031 |
6.1.7 Global Next Generation Sequencing Market, Revenues & Volume, By De Novo Sequencing, 2021 - 2031 |
6.1.8 Global Next Generation Sequencing Market, Revenues & Volume, By Methyl Sequencing, 2021 - 2031 |
6.1.9 Global Next Generation Sequencing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Next Generation Sequencing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Next Generation Sequencing Market, Revenues & Volume, By Instruments, 2021 - 2031 |
6.2.3 Global Next Generation Sequencing Market, Revenues & Volume, By Reagents and Consumables, 2021 - 2031 |
6.2.4 Global Next Generation Sequencing Market, Revenues & Volume, By Software and Services, 2021 - 2031 |
6.3 Global Next Generation Sequencing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Next Generation Sequencing Market, Revenues & Volume, By Instruments, 2021 - 2031 |
6.3.3 Global Next Generation Sequencing Market, Revenues & Volume, By Reagents and Consumables, 2021 - 2031 |
6.3.4 Global Next Generation Sequencing Market, Revenues & Volume, By Software and Services, 2021 - 2031 |
6.4 Global Next Generation Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Next Generation Sequencing Market, Revenues & Volume, By Biomarker and Cancer, 2021 - 2031 |
6.4.3 Global Next Generation Sequencing Market, Revenues & Volume, By Drug Discovery and Personalized Medicine, 2021 - 2031 |
6.4.4 Global Next Generation Sequencing Market, Revenues & Volume, By Genetic Screening, 2021 - 2031 |
6.4.5 Global Next Generation Sequencing Market, Revenues & Volume, By Diagnostics, 2021 - 2031 |
6.4.6 Global Next Generation Sequencing Market, Revenues & Volume, By Agriculture and Animal Research, 2021 - 2031 |
6.4.7 Global Next Generation Sequencing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Next Generation Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Next Generation Sequencing Market, Revenues & Volume, By Academic Institutes and Research Centers, 2021 - 2031 |
6.5.3 Global Next Generation Sequencing Market, Revenues & Volume, By Hospitals and Clinics, 2021 - 2031 |
6.5.4 Global Next Generation Sequencing Market, Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021 - 2031 |
6.5.5 Global Next Generation Sequencing Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Next Generation Sequencing Market, Overview & Analysis |
7.1 North America Next Generation Sequencing Market Revenues & Volume, 2021 - 2031 |
7.2 North America Next Generation Sequencing Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Next Generation Sequencing Market, Revenues & Volume, By Sequencing Type, 2021 - 2031 |
7.4 North America Next Generation Sequencing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5 North America Next Generation Sequencing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.6 North America Next Generation Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7 North America Next Generation Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Next Generation Sequencing Market, Overview & Analysis |
8.1 Latin America (LATAM) Next Generation Sequencing Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Next Generation Sequencing Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Next Generation Sequencing Market, Revenues & Volume, By Sequencing Type, 2021 - 2031 |
8.4 Latin America (LATAM) Next Generation Sequencing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.5 Latin America (LATAM) Next Generation Sequencing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.6 Latin America (LATAM) Next Generation Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
8.7 Latin America (LATAM) Next Generation Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Next Generation Sequencing Market, Overview & Analysis |
9.1 Asia Next Generation Sequencing Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Next Generation Sequencing Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Next Generation Sequencing Market, Revenues & Volume, By Sequencing Type, 2021 - 2031 |
9.4 Asia Next Generation Sequencing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.5 Asia Next Generation Sequencing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.6 Asia Next Generation Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
9.7 Asia Next Generation Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Next Generation Sequencing Market, Overview & Analysis |
10.1 Africa Next Generation Sequencing Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Next Generation Sequencing Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Next Generation Sequencing Market, Revenues & Volume, By Sequencing Type, 2021 - 2031 |
10.4 Africa Next Generation Sequencing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.5 Africa Next Generation Sequencing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.6 Africa Next Generation Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
10.7 Africa Next Generation Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Next Generation Sequencing Market, Overview & Analysis |
11.1 Europe Next Generation Sequencing Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Next Generation Sequencing Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Next Generation Sequencing Market, Revenues & Volume, By Sequencing Type, 2021 - 2031 |
11.4 Europe Next Generation Sequencing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.5 Europe Next Generation Sequencing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.6 Europe Next Generation Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
11.7 Europe Next Generation Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Next Generation Sequencing Market, Overview & Analysis |
12.1 Middle East Next Generation Sequencing Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Next Generation Sequencing Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Next Generation Sequencing Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Next Generation Sequencing Market, Revenues & Volume, By Sequencing Type, 2021 - 2031 |
12.4 Middle East Next Generation Sequencing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.5 Middle East Next Generation Sequencing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.6 Middle East Next Generation Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
12.7 Middle East Next Generation Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Next Generation Sequencing Market Key Performance Indicators |
14 Global Next Generation Sequencing Market - Export/Import By Countries Assessment |
15 Global Next Generation Sequencing Market - Opportunity Assessment |
15.1 Global Next Generation Sequencing Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Next Generation Sequencing Market Opportunity Assessment, By Sequencing Type, 2021 & 2031F |
15.3 Global Next Generation Sequencing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.4 Global Next Generation Sequencing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.5 Global Next Generation Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
15.6 Global Next Generation Sequencing Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Next Generation Sequencing Market - Competitive Landscape |
16.1 Global Next Generation Sequencing Market Revenue Share, By Companies, 2024 |
16.2 Global Next Generation Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here